Disease and economic burden of rotavirus diarrhoea in India

• Published in: Vaccine Vol. 27; pp. F18 - F24
• Main Authors: Tate, Jacqueline E, Chitambar, Shobha, Esposito, Douglas H, Sarkar, Rajiv, Gladstone, Beryl, Ramani, Sasirekha, Raghava, Mohan Venkata, Sowmyanarayanan, Thuppal V, Gandhe, Swati, Arora, Rashmi, Parashar, Umesh D, Kang, Gagandeep
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier Ltd 20-11-2009
• Subjects: Allergy and Immunology; Child, Preschool; Cost of Illness; Diarrhea - economics; Diarrhea - mortality; Diarrhea - prevention & control; Disease burden; Health Care Costs; Hospitalization - statistics & numerical data; Humans; India; Outpatient Clinics, Hospital - statistics & numerical data; Rotavirus; Rotavirus Infections - economics; Rotavirus Infections - mortality; Rotavirus Infections - prevention & control; Rotavirus Vaccines - administration & dosage; India; Rs; World Health Organization; CHERG; Indian rupees; Rotavirus; United States; Christian Medical College; NFHS; Disease burden; India; Child Health Epidemiology Reference Group; CHAD; CMC; Community Health and Development Hospital; National Family Health Survey; US; WHO
• ISSN: 0264-410X; 1873-2518
• DOI: 10.1016/j.vaccine.2009.08.098

Abstract We used published and unpublished studies and national statistics to estimate the number of deaths, hospitalizations, and outpatient visits due to rotavirus diarrhoea and the associated national economic burden of disease in India. Annually in India, rotavirus diarrhoea causes an estimated 122,000–153,000 deaths, 457,000–884,000 hospitalizations, and 2 million outpatient visits in children <5 years of age. India spends Rs 2.0–3.4 billion (US$ 41–72 million) annually in medical costs to treat rotavirus diarrhoea. The use of specific interventions against rotavirus, such as newly available vaccines, would help prevent much of this large disease and economic burden.